How much is Linnaeus Therapeutics worth in 2026?

Linnaeus Therapeutics has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Linnaeus Therapeutics raised?

Linnaeus Therapeutics has raised $30.9M in total funding across 1 funding rounds.

Linnaeus Therapeutics

Drug DiscoveryWebsite

Linnaeus Therapeutics valuation and funding history | Last updated: August 22, 2025 | 1 funding rounds

Current Valuation

N/A

As of August 22, 2025

Total Funding Raised

$30.9M

Across 1 round

Last Round

Later Stage VC

$1.3M

Last Funding

Aug 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 1, 2023	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Linnaeus Therapeutics is currently valued at N/A as of August 22, 2025. The company has raised a total of $30.9M in funding across 1 funding round.

Track Linnaeus Therapeutics Valuation Updates

Get notified when Linnaeus Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Linnaeus Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Linnaeus Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Linnaeus Therapeutics Worth in 2026?

Linnaeus Therapeutics is a leading private company in the Drug Discovery sector. Track Linnaeus Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Linnaeus Therapeutics Valuation is Determined

Private company valuations like Linnaeus Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.